IMARC Group’s latest report, titled “Medical Affairs Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” finds that the global medical affairs outsourcing market is anticipated to exhibit a CAGR of 12.27% during 2024-2032. Medical affairs outsourcing is a process that provides patients, medical staff, and governmental organizations with detailed insights into healthcare policies, operations, and patient information. It offers affordable and flexible solutions for dealing with the common problems faced by the industry and allows original equipment manufacturers (OEMs) to optimally use healthcare resources, strategic management, and resource components. It is used by healthcare organizations to comply with the strict regulatory policies of various countries successfully. It aids in the development of new products and the evaluation of existing drug indications. As a result, medical affairs outsourcing finds extensive applications across pharmaceutical, biotechnology, and medical device companies to effectively complete the pre- and post-production stages and clinical trials of medical products.
Global Medical Affairs Outsourcing Market Trends:
The rising number of clinical trials due to the expanding geriatric population and the increasing prevalence of various communicable and non-communicable diseases represents the primary factor driving the market growth. Moreover, clinical trials help determine the safety standards and efficacy of therapeutic strategies, medications, and equipment. In line with this, the increasing development of new drugs and medical equipment is positively influencing market growth. Additionally, the surging adoption of orphan therapies to treat rare diseases and the advancement of medical education have augmented the product demand. Besides this, the shifting consumer preferences toward specialty drugs are promoting the uptake of medical affairs outsourcing to produce complex patient outcomes data related to specialized therapy areas, which in turn is propelling the market growth. Along with this, the rising inclination of several medical, pharmaceutical, biotechnological, medical device, and diagnostic organizations to outsource medical services and products in an effort to diversify their business operations and maintain the product life cycle is contributing to the market growth. Furthermore, the increasing need for customized medical affairs outsourcing in the biotherapeutics industry to reallocate resources and maximize commercial opportunities due to the rising number of medications in pipelines has catalyzed market growth. Other factors, including the escalating demand for professional medical writers, improving healthcare infrastructure, and rising partnerships among clinical research organizations, are also anticipated to create a favorable market outlook.
Market Summary:
- Based on the services, the market has been divided into medical writing and publishing, medical monitoring, medical science liaisons (MSLs), medical information, and others. Currently, the medical writing and publishing segment dominates the market.
- On the basis of the end use industry, the market has been segmented into pharmaceutical, medical devices, and other companies, wherein pharmaceutical companies account for the largest market share.
- Region-wise, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. Amongst these, North America holds the leading position in the market.
- The competitive landscape of the market has also been examined, with some of the key players being Inizio, Icon plc, IQVIA Inc., PPD, Inc. (Thermo Fisher Scientific Inc.), SGS S.A., Indegene Limited, Syneos Health, The Medical Affairs Company (Parexel International Corporation) and WuXi Clinical (WuXi AppTec).
Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Services, End Use Industry, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Inizio, Icon plc, IQVIA Inc., PPD, Inc. (Thermo Fisher Scientific Inc.), SGS S.A., Indegene Limited, Syneos Health, The Medical Affairs Company (Parexel International Corporation) and WuXi Clinical (WuXi AppTec) |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800